Skip to main content

View full-text article in PMC

. 2021 Dec 23;13(3):369–379. doi: 10.1111/1759-7714.14265

TABLE 1.

The clinicopathological information of TCGA‐LUAD patients

Characteristic	Levels	Overall
n		513
T stage, n (%)	T1	168 (32.9%)
	T2	276 (54.1%)
	T3	47 (9.2%)
	T4	19 (3.7%)
N stage, n (%)	N0	330 (65.9%)
	N1	95 (19%)
	N2	74 (14.8%)
	N3	2 (0.4%)
M stage, n (%)	M0	344 (93.2%)
M stage, n (%)	M1	25 (6.8%)
Pathological stage, n (%)	Stage I	274 (54.3%)
	Stage II	121 (24%)
	Stage III	84 (16.6%)
	Stage IV	26 (5.1%)
Gender, n (%)	Female	276 (53.8%)
Gender, n (%)	Male	237 (46.2%)
Age, n (%)	<=65	238 (48.2%)
Age, n (%)	>65	256 (51.8%)
Age, median (IQR)		66 (59, 72.75)